Nomura Asset Management CO LTD Neurocrine Biosciences Inc Transaction History

Nomura Asset Management CO LTD

$28.9 Billion
Q2 2024

A detailed history of Nomura Asset Management CO LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 57,748 shares of NBIX stock, worth $7.25 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

57,748

Previous 63,182 8.6%

Holding current value

$7.25 Million

Previous $8.71 Million 8.77%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $711,093 - $778,094	-5,434 Reduced 8.6%	57,748 $7.95 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $55,159 - $60,802	-423 Reduced 0.67%	63,182 $8.71 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $10,607 - $13,276	100 Added 0.16%	63,605 $8.38 Million
Q3 2023 Nov 03, 2023	SELL	$94.02 - $117.1 $524,631 - $653,418	-5,580 Reduced 8.08%	63,505 $7.14 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $8,953 - $10,487	100 Added 0.14%	69,085 $6.51 Million
Q1 2023 May 11, 2023	BUY	$94.11 - $123.02 $3.08 Million - $4.03 Million	32,756 Added 90.41%	68,985 $6.98 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $234,784 - $279,532	2,200 Added 6.47%	36,229 $4.33 Million
Q2 2022 Aug 12, 2022	BUY	$75.79 - $100.07 $159,159 - $210,147	2,100 Added 6.58%	34,029 $3.32 Million
Q4 2021 Feb 01, 2022	BUY	$79.65 - $106.22 $1.08 Million - $1.44 Million	13,529 Added 73.53%	31,929 $2.72 Million
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $1.14 Million - $1.31 Million	-13,209 Reduced 41.79%	18,400 $1.77 Million
Q2 2021 Aug 06, 2021	BUY	$89.43 - $102.27 $118,673 - $135,712	1,327 Added 4.38%	31,609 $3.08 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $94,750 - $129,190	-1,082 Reduced 3.45%	30,282 $2.95 Million
Q4 2020 Feb 12, 2021	BUY	$86.91 - $108.33 $37,284 - $46,473	429 Added 1.39%	31,364 $3.01 Million
Q2 2020 Aug 13, 2020	BUY	$85.09 - $130.36 $110,957 - $169,989	1,304 Added 4.4%	30,935 $3.78 Million
Q1 2020 May 14, 2020	BUY	$75.11 - $113.76 $105,154 - $159,264	1,400 Added 4.96%	29,631 $2.57 Million
Q4 2019 Feb 13, 2020	BUY	$86.8 - $118.57 $1.18 Million - $1.61 Million	13,620 Added 93.22%	28,231 $3.04 Million
Q2 2017 Aug 14, 2017	BUY	N/A	14,611	14,611 $672,000

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Neurocrine Biosciences Inc Transaction History